In Vitro Evaluation of Caffeoyl and Cinnamoyl Derivatives as Potential Prolyl Oligopeptidase Inhibitors

被引:9
|
作者
Adolpho, Luciana O. [1 ]
Marin, Daniele [1 ]
Puigpinos, Albert [2 ]
Mendieta, Laura [2 ]
Tarrago, Teresa [2 ]
Morel, Ademir F. [1 ]
Giralt, Ernest [2 ]
Dalcol, Ionara I. [1 ]
机构
[1] Univ Fed Santa Maria, Dept Chem, Nucleo Pesquisa Prod Nat, BR-97105900 Santa Maria, RS, Brazil
[2] Inst Res Biomed, Barcelona, Spain
关键词
prolyl oligopeptidase; dipeptidyl peptidase IV; chlorogenic acid; caffeoyl and cinnamoyl derivatives; Hypericum brasiliense; Hypericaceae; ENDOPEPTIDASE INHIBITOR; ACID-DERIVATIVES; CHLOROGENIC ACID; ANTIOXIDANT; JTP-4819; TARGET; ESTERS;
D O I
10.1055/s-0033-1350897
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
A screening of the natural product chlorogenic acid, isolated from the Brazilian medicinal plant Hypericum brasiliense, caffeic acid, cinnamic acid, and p-methoxycinnamic acid, and derivatives of caffeoylquinic, caffeoyl, and cinnamoyl against the enzymes prolyl oligopeptidase and dipeptidyl peptidase IV was carried out. Caffeoylquinic, caffeoyl, and cinnamoyl derivatives were prepared using simple derivatization procedures and through coupling reactions with the amino acid proline. The dipeptidyl peptidase IV assay showed inhibitory activity of the tested compounds at a high concentration (500 mu M) in the range of 81.5-7.2%. In contrast, the derivatives methyl ester and 1,7-acetonide obtained from chlorogenic acid, and caffeic acid and its methyl ester derivative showed selectivity and activity as prolyl oligopeptidase inhibitors, with IC50 values of 3 to 14mM.
引用
收藏
页码:1531 / 1535
页数:5
相关论文
共 50 条
  • [21] Indole-based thiosemicarbazones for neurodegenerative diseases as prolyl oligopeptidase inhibitors
    Pasha, Anam Rubbab
    Khan, Ajmal
    Ullah, Saeed
    Halim, Sobia Ahsan
    Alharthy, Rima D.
    Anwar, Muhammad Usman
    Hussain, Javid
    Naseer, Muhammad Moazzam
    Kashtoh, Hamdy
    Al-Harrasi, Ahmed
    Shafiq, Zahid
    Boshta, Nader M.
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1312
  • [22] Synthesis and Evaluation of Succinic Acid Derivatives as Prolyl Endopeptidase Inhibitors
    Yoon, Seung-Bin
    Yang, Jae-Sung
    Lee, Kyung-Ho
    Han, Hyeon-Gyu
    Han, Ah-Reum
    Paik, Young-Sook
    JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY, 2011, 54 (05): : 731 - 737
  • [23] Synthesis and evaluation of succinic acid derivatives as prolyl endopeptidase inhibitors
    Seung-Bin Yoon
    Jae-Sung Yang
    Kyung-Ho Lee
    Hyeon-Gyu Han
    Ah-Reum Han
    Young-Sook Paik
    Journal of the Korean Society for Applied Biological Chemistry, 2011, 54 (5): : 731 - 737
  • [24] Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP)
    Haffner, Curt D.
    Diaz, Caroline J.
    Miller, Aaron B.
    Reid, Robert A.
    Madauss, Kevin P.
    Hassell, Annie
    Hanlon, Mary H.
    Porter, David J. T.
    Becherer, J. David
    Carter, Luke H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4360 - 4363
  • [25] Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors
    Kratky, Martin
    Stepankova, Sarka
    Vorcakova, Katarina
    Vinsova, Jarmila
    BIOORGANIC CHEMISTRY, 2016, 68 : 23 - 29
  • [26] Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors
    Wallén, EAA
    Christiaans, JAM
    Saarinen, TJ
    Jarho, EM
    Forsberg, MM
    Venäläinen, JI
    Männistö, PT
    Gynther, J
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (17) : 3611 - 3619
  • [27] Development and evaluation of peptide-based prolyl oligopeptidase inhibitors - Introduction of N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine as a lead in inhibitor design
    Goossens, F
    Vanhoof, G
    DeMeester, I
    Augustyns, K
    Borloo, M
    Tourwe, D
    Haemers, A
    Scharpe, S
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (01): : 177 - 183
  • [28] PROLYL DERIVATIVES OF ENALAPRIL AS POTENTIAL ANGIOTENSIN CONVERTING ENZYME-INHIBITORS
    CIABATTI, R
    TARZIA, G
    BATTAGLIA, F
    BARONE, D
    BALDOLI, E
    FARMACO-EDIZIONE SCIENTIFICA, 1988, 43 (12): : 989 - 1003
  • [29] Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-? for different indications
    Plescia, Jessica
    Hedou, Damien
    Pousse, Maud Eva
    Labarre, Anne
    Dufresne, Caroline
    Mittermaier, Anthony
    Moitessier, Nicolas
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [30] Evaluation of acetylcholinesterase and prolyl oligopeptidase inhibition of novel amino acid-functionalized stigmasterol and ursolic acid derivatives
    Seixas N.
    Dalcol I.I.
    Ravanello B.
    Alessio K.
    Duarte F.A.
    Bender V.
    Morel A.F.
    Current Organic Chemistry, 2019, 23 (19): : 2131 - 2140